Tamoxifen: Five versus ten years - Is the end in sight?

被引：11

作者：

Abrams, JA ^{[1
]}

机构：

[1] NCI, Canc Therapy Evaluat Program, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2001年 / 93卷 / 09期

关键词：

D O I：

10.1093/jnci/93.9.662

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

下载

页码：662 / 664

页数：3

共 50 条

[1] Five years of tamoxifen - Or more?
Peto, R
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (24) : 1791 - 1793
[2] Ten Years of Litigation by Heirs of Ottoman Armenians for Unpaid Insurance Proceeds: An End in Sight?
Saltzman, David
Neuwirth, Esther
MIDDLE EAST CRITIQUE, 2011, 20 (03) : 341 - 357
[3] Ten technologies in five years
Jaffe, S
SCIENTIST, 2004, 18 (23): : 29 - 31
[4] 75 years of excellence with no end in sight
Lowther, GE
OPTOMETRY AND VISION SCIENCE, 1998, 75 (01) : 1 - 2
[5] Five Acknowledgments for Ten Years of Existence
Javier Murillo, F.
REICE-REVISTA IBEROAMERICANA SOBRE CALIDAD EFICACIA Y CAMBIO EN EDUCACION, 2012, 10 (03): : 4 - 5
[6] Surgery plus tamoxifen versus tamoxifen as treatment of stage I and II breast cancer in over to 70 years old women: Ten years follow-up.
Capasso, I
Nuzzo, F
Labonia, V
Landi, G
Rossi, E
de Matteis, A
ANNALS OF ONCOLOGY, 2000, 11 : 20 - 20
[7] 100 Years of Insulin Development and no End in sight
Forst, T.
DIABETES STOFFWECHSEL UND HERZ, 2021, 30 (04): : 272 - 280
[8] Letrozole in postmenopausal women after five years on tamoxifen
Edith A. Perez
Current Oncology Reports, 2004, 6 (1) : 74 - 74
[9] Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
Machin, D
Andersen, KW
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09): : 659 - 659
[10] Randomized trial of two versus five years of adjuvant tamoxifen for postmenopausal early stage breast cancer
Rutqvist, LE
Hatschek, T
Ryden, S
Bergh, J
Bengtsson, NO
Carstenssen, J
Nordenskjold, B
Wallgren, A
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1996, 88 (21) : 1543 - 1549

← 1 2 3 4 5 →